Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
NetraMark Holdings ( (TSE:AIAI) ) has shared an announcement.
NetraMark Holdings Inc., in collaboration with the Centre for Addiction and Mental Health (CAMH), has been awarded the Ontario Research Fund – Research Excellence Award to advance AI-driven research in schizophrenia and depression. This partnership will utilize NetraMark’s NetraAI platform to analyze genetic and epigenetic data, aiming to identify patient subpopulations and improve precision treatment strategies. The initiative is expected to enhance NetraAI’s capabilities, benefiting pharmaceutical sponsors and potentially transforming psychiatric treatment approaches.
More about NetraMark Holdings
NetraMark Holdings Inc. is a leading artificial intelligence company specializing in AI-powered precision analytics for the pharmaceutical industry. The company focuses on developing Generative Artificial Intelligence and Machine Learning solutions to enhance clinical trials, using a unique topology-based algorithm to analyze patient data effectively.
Average Trading Volume: 50,157
Technical Sentiment Signal: Hold
Current Market Cap: C$103M
Learn more about AIAI stock on TipRanks’ Stock Analysis page.